triiodothyronine has been researched along with Follicular Thyroid Carcinoma in 25 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We experienced two cases of follicular thyroid carcinoma with distant metastases, which showed high levels of free triiodothyronine (T(3)) while free thyroxine (T(4)) levels remained in the low or normal range." | 7.73 | Thyroxine to triiodothyronine hyperconversion thyrotoxicosis in patients with large metastases of follicular thyroid carcinoma. ( Amino, N; Ito, Y; Miyauchi, A; Takano, T, 2006) |
| "We experienced two cases of follicular thyroid carcinoma with distant metastases, which showed high levels of free triiodothyronine (T(3)) while free thyroxine (T(4)) levels remained in the low or normal range." | 3.73 | Thyroxine to triiodothyronine hyperconversion thyrotoxicosis in patients with large metastases of follicular thyroid carcinoma. ( Amino, N; Ito, Y; Miyauchi, A; Takano, T, 2006) |
| "In both, thyroid cancer is driven by overactivation of PI3K-AKT signaling." | 1.43 | SAHA-induced loss of tumor suppressor Pten gene promotes thyroid carcinogenesis in a mouse model. ( Cheng, SY; Kim, DW; Willingham, MC; Zhao, L; Zhu, X, 2016) |
| "We used the human follicular thyroid cancer cell lines (FTC-133 and FTC-236 cells) to elucidate how functional expression of the THRB gene could affect tumorigenesis." | 1.40 | Inhibition of tumorigenesis by the thyroid hormone receptor β in xenograft models. ( Cheng, SY; Kim, DW; Kim, WG; Willingham, MC; Zhao, L, 2014) |
| "In patients with differentiated thyroid cancer (DTC), the stimulated serum thyroglobulin (Tg) level at radioiodine ablation is a known predictive factor of persistent disease." | 1.40 | Stimulated thyroglobulin level at ablation in differentiated thyroid cancer: the impact of treatment preparation modalities and tumor burden. ( Bardet, S; Blanchard, D; Ciappuccini, R; de Raucourt, D; Hardouin, J; Heutte, N; Quak, E; Rame, JP; Vaur, D, 2014) |
| "Trifluralin treatment increased bile flow, caused a 3." | 1.35 | Mechanism of trifluralin-induced thyroid tumors in rats. ( Bartels, MJ; Brzak, KA; Charles, GD; Clark, AJ; Dryzga, MD; Kan, LH; Saghir, SA, 2008) |
| "We report a case of follicular thyroid carcinoma discovered after surgical treatment of a toxic multinodular goiter, in which solitary adrenal gland metastasis was detected five years later." | 1.31 | Solitary adrenal gland metastasis of a follicular thyroid carcinoma presenting with hyperthyroidism. ( López-Aznar, D; Ponce, JL; Prieto, M; Sancho-Fornos, S; Yunta, PJ, 2001) |
| "The most probable cause of the inadequate TSH suppression in our patients was the reduction in bioavailability in certain batches of Levothroid, although we are unable to rule out the possibility that the results obtained after the changeover to Dexnon were due to its greater bioavailability." | 1.30 | Altered bioavailability due to changes in the formulation of a commercial preparation of levothyroxine in patients with differentiated thyroid carcinoma. ( Almaraz, MC; Garriga, MJ; Gonzalez-Romero, S; Olveira, G; Ruiz de Adana, MS; Soriguer, F; Tinahones, F, 1997) |
| "In the follicular thyroid carcinoma line FTC-133, nanomolar concentrations of 9-cis, 13-cis-, and all-trans-RA induced 5'DI activity." | 1.29 | Retinoids stimulate type I iodothyronine 5'-deiodinase activity in human follicular thyroid carcinoma cell lines. ( Köhrle, J; Schmutzler, C; Schnieders, F; Schreck, R, 1994) |
| "In a study of 136 differentiated thyroid cancer patients referred for radioiodine therapy since January 1991, it was observed that 80 patients had metastatic disease." | 1.29 | Thyroid hormones in differentiated thyroid cancer. ( Desai, KB; Mehta, MN; Samuel, AM, 1994) |
| "in an advanced stage with multiple metastases in the skeletal system, lungs and hilar lymph nodes." | 1.29 | [T3 hyperthyroidism with metastatic follicular thyroid carcinoma in substitution therapy]. ( Flesch, M; Lang, M, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (36.00) | 18.2507 |
| 2000's | 9 (36.00) | 29.6817 |
| 2010's | 7 (28.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fussey, JM | 1 |
| Khan, H | 1 |
| Ahsan, F | 1 |
| Prashant, R | 1 |
| Pettit, L | 1 |
| Kim, WG | 1 |
| Zhao, L | 3 |
| Kim, DW | 2 |
| Willingham, MC | 3 |
| Cheng, SY | 3 |
| Ciappuccini, R | 1 |
| Hardouin, J | 1 |
| Heutte, N | 1 |
| Vaur, D | 1 |
| Quak, E | 1 |
| Rame, JP | 1 |
| Blanchard, D | 1 |
| de Raucourt, D | 1 |
| Bardet, S | 1 |
| Zhu, X | 1 |
| Saghir, SA | 1 |
| Charles, GD | 1 |
| Bartels, MJ | 1 |
| Kan, LH | 1 |
| Dryzga, MD | 1 |
| Brzak, KA | 1 |
| Clark, AJ | 1 |
| Gen, R | 1 |
| Akbay, E | 1 |
| Camsari, A | 1 |
| Ozcan, T | 1 |
| Lu, C | 1 |
| Ying, H | 1 |
| Taïeb, D | 1 |
| Sebag, F | 1 |
| Farman-Ara, B | 1 |
| Portal, T | 1 |
| Baumstarck-Barrau, K | 1 |
| Fortanier, C | 1 |
| Bourrelly, M | 1 |
| Mancini, J | 1 |
| De Micco, C | 1 |
| Auquier, P | 1 |
| Conte-Devolx, B | 1 |
| Henry, JF | 1 |
| Mundler, O | 1 |
| Depczynski, B | 1 |
| Lillioja, S | 1 |
| Takano, T | 1 |
| Miyauchi, A | 2 |
| Ito, Y | 2 |
| Amino, N | 2 |
| Takamura, Y | 1 |
| Miya, A | 1 |
| Kobayashi, K | 1 |
| Matsuzuka, F | 1 |
| Toyoda, N | 1 |
| Nomura, E | 1 |
| Nishikawa, M | 1 |
| David, E | 1 |
| Rosen, IB | 1 |
| Bain, J | 1 |
| James, J | 1 |
| Kirsh, JC | 1 |
| Francia, G | 1 |
| Davì, MV | 1 |
| Petroziello, A | 1 |
| Sussi, PL | 1 |
| Schreck, R | 1 |
| Schnieders, F | 1 |
| Schmutzler, C | 2 |
| Köhrle, J | 2 |
| Samuel, AM | 1 |
| Mehta, MN | 1 |
| Desai, KB | 1 |
| Johansen, AH | 1 |
| Nielsen, BV | 1 |
| Lang, M | 1 |
| Flesch, M | 1 |
| Olveira, G | 1 |
| Almaraz, MC | 1 |
| Soriguer, F | 1 |
| Garriga, MJ | 1 |
| Gonzalez-Romero, S | 1 |
| Tinahones, F | 1 |
| Ruiz de Adana, MS | 1 |
| Naito, Y | 1 |
| Sone, T | 1 |
| Kataoka, K | 1 |
| Sawada, M | 1 |
| Yamazaki, K | 1 |
| Konukoğlu, D | 1 |
| Hatemi, HH | 1 |
| Arikan, S | 1 |
| Demir, M | 1 |
| Akçay, T | 1 |
| Schönberger, J | 1 |
| Bauer, J | 1 |
| Spruss, T | 1 |
| Weber, G | 1 |
| Chahoud, I | 1 |
| Eilles, C | 1 |
| Grimm, D | 1 |
| Kondo, T | 1 |
| Katoh, R | 1 |
| Omata, K | 1 |
| Oyama, T | 1 |
| Yagawa, A | 1 |
| Kawaoi, A | 1 |
| Yunta, PJ | 1 |
| Ponce, JL | 1 |
| Prieto, M | 1 |
| López-Aznar, D | 1 |
| Sancho-Fornos, S | 1 |
| Schmitt, TL | 1 |
| Glaser, F | 1 |
| Loos, U | 1 |
| Ishihara, T | 1 |
| Ikekubo, K | 1 |
| Shimodahira, M | 1 |
| Iwakura, T | 1 |
| Kobayashi, M | 1 |
| Hino, M | 1 |
| Oobayashi, M | 1 |
| Kohno, K | 1 |
| Kimura, K | 1 |
| Kawamura, S | 1 |
| Kurahachi, H | 1 |
1 review available for triiodothyronine and Follicular Thyroid Carcinoma
| Article | Year |
|---|---|
Thyroid-stimulating hormone suppression therapy for differentiated thyroid cancer: The role for a combined T3/T4 approach.
Topics: Adenocarcinoma, Follicular; Combined Modality Therapy; Drug Therapy, Combination; Evidence-Based Med | 2017 |
1 trial available for triiodothyronine and Follicular Thyroid Carcinoma
| Article | Year |
|---|---|
Iodine biokinetics and radioiodine exposure after recombinant human thyrotropin-assisted remnant ablation in comparison with thyroid hormone withdrawal.
Topics: Ablation Techniques; Adenocarcinoma, Follicular; Carcinoma, Papillary; Combined Modality Therapy; Ha | 2010 |
23 other studies available for triiodothyronine and Follicular Thyroid Carcinoma
| Article | Year |
|---|---|
Inhibition of tumorigenesis by the thyroid hormone receptor β in xenograft models.
Topics: Adenocarcinoma, Follicular; Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Heterografts; Humans | 2014 |
Stimulated thyroglobulin level at ablation in differentiated thyroid cancer: the impact of treatment preparation modalities and tumor burden.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Carcinoma; Carcinoma, Papillary; Female; Humans; Iodine Rad | 2014 |
SAHA-induced loss of tumor suppressor Pten gene promotes thyroid carcinogenesis in a mouse model.
Topics: Adenocarcinoma, Follicular; Animals; Carcinogenesis; Disease Models, Animal; Hydroxamic Acids; Mice, | 2016 |
Mechanism of trifluralin-induced thyroid tumors in rats.
Topics: Adenocarcinoma, Follicular; Administration, Oral; Animal Feed; Animals; Dose-Response Relationship, | 2008 |
P-wave dispersion in endogenous and exogenous subclinical hyperthyroidism.
Topics: Adenocarcinoma, Follicular; Adenoma; Atrial Fibrillation; Carcinoma, Papillary; Electrocardiography; | 2010 |
Growth activation alone is not sufficient to cause metastatic thyroid cancer in a mouse model of follicular thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Animals; Blotting, Western; Cell Proliferation; Disease Models, Animal; | 2010 |
Two cases of thyroid carcinoma that were not stimulated by recombinant human thyrotropin.
Topics: Adenocarcinoma, Follicular; Humans; Recombinant Proteins; Thyroid Neoplasms; Thyrotropin; Triiodothy | 2004 |
Thyroxine to triiodothyronine hyperconversion thyrotoxicosis in patients with large metastases of follicular thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adult; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Mid | 2006 |
3,5,3'-Triiodothyronine thyrotoxicosis due to increased conversion of administered levothyroxine in patients with massive metastatic follicular thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Aged, 80 and over; Disease Progression; Female; Humans; Iod | 2008 |
Management of the hot thyroid nodule.
Topics: Adenocarcinoma; Adenocarcinoma, Follicular; Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma; D | 1995 |
[Hormonal therapy in differentiated carcinoma of the thyroid gland].
Topics: Adenocarcinoma, Follicular; Adenylyl Cyclases; Biomarkers, Tumor; Carcinoma; Carcinoma, Papillary; H | 1994 |
Retinoids stimulate type I iodothyronine 5'-deiodinase activity in human follicular thyroid carcinoma cell lines.
Topics: Adenocarcinoma, Follicular; Affinity Labels; Butyrates; Butyric Acid; Cycloheximide; Dactinomycin; H | 1994 |
Thyroid hormones in differentiated thyroid cancer.
Topics: Adenocarcinoma, Follicular; Bone Neoplasms; Humans; Iodine Radioisotopes; Thyroglobulin; Thyroid Neo | 1994 |
[T3 thyrotoxicosis in a patient with a hormonally active, metastasizing follicular thyroid carcinoma].
Topics: Adenocarcinoma, Follicular; Female; Humans; Lung Neoplasms; Middle Aged; Thyroid Neoplasms; Thyrotox | 1994 |
[T3 hyperthyroidism with metastatic follicular thyroid carcinoma in substitution therapy].
Topics: Adenocarcinoma, Follicular; Adult; Female; Humans; Hyperthyroidism; Iodine Radioisotopes; Lymphatic | 1996 |
Altered bioavailability due to changes in the formulation of a commercial preparation of levothyroxine in patients with differentiated thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Adult; Aged; Biological Availability; Carcinoma, Papillary; Chemistry, P | 1997 |
Thyroid storm due to functioning metastatic thyroid carcinoma in a burn patient.
Topics: Adenocarcinoma, Follicular; Burns; Humans; Male; Middle Aged; Thyroid Crisis; Thyroid Neoplasms; Thy | 1997 |
Radioiodine treatment and oxidative stress in thyroidectomised patients for differentiated thyroid cancers.
Topics: Adenocarcinoma, Follicular; Adult; Biomarkers; Carcinoma, Papillary; Erythrocyte Count; Erythrocytes | 1998 |
Establishment and characterization of the follicular thyroid carcinoma cell line ML-1.
Topics: Adenocarcinoma, Follicular; Animals; Cell Transplantation; Deoxyglucose; DNA, Neoplasm; Female; Flow | 2000 |
Incidentally detected liver metastasis of well-differentiated follicular carcinoma of the thyroid, mimicking ectopic thyroid.
Topics: Adenocarcinoma, Follicular; Cell Differentiation; Choristoma; Diagnosis, Differential; Female; Human | 2000 |
Solitary adrenal gland metastasis of a follicular thyroid carcinoma presenting with hyperthyroidism.
Topics: Adenocarcinoma, Follicular; Adrenal Gland Neoplasms; Diagnosis, Differential; Goiter, Nodular; Human | 2001 |
The promoter of the human sodium/iodide-symporter gene responds to retinoic acid.
Topics: Adenocarcinoma, Follicular; Animals; Genes, Reporter; Humans; Iodine Radioisotopes; Oligonucleotides | 2002 |
A case of TSH receptor antibody-positive hyperthyroidism with functioning metastases of thyroid carcinoma.
Topics: Adenocarcinoma, Follicular; Aged; Antithyroid Agents; Autoantibodies; Bone Neoplasms; Female; Humans | 2002 |